Search
for
Sort by
Research 301–330 of 1000+
- Dermatologia e Procedimentos Estéticos Ed. XXVII
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- Arabidopsis retromer subunit AtVPS29 is involved in SLY1-mediated gibberellin signaling
- POSTĘP W DIAGNOZIE I LECZENIU STWARDNIENIA ROZSIANEGO
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION
- MICRO-URZĄDZENIA, BEZPRZEWODOWE KAPSUŁKI, MAPY, STYMULATORY I ROZRUSZNIKI STOSOWANE DO DIAGNOSTYKI I LECZENIA ZABURZEŃ MOTORYKI PRZEWODU POKARMOWEGO
- EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- Refractory Folliculitis Decalvans Treatment Success with a Novel Surgical Excision Approach Using Guarded High-Tension Sutures
- Dupilumab: Friend or Foe to Alopecia Areata?
- Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
- More Yellow Ovaries
- Crash Dieter's Hair Loss
- Wording Creates Misunderstanding
- Adverse Reactions to Enemas
- Raynaud Phenomenon
- The women’s hair growth questionnaire: Development and validation of a patient-reported measure for treatment efficacy in androgenetic alopecia
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Ritlecitinib: First Approval
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia